Skip to content
MedsAcross

Medicine

Ertapenem 1 g powder for injection

Ertapenem · Intramuscular, intravenous
Available on requestPrescription onlyUS FDAGeneric name

Ertapenem 1 g powder for injection is a generic prescription medicine for intramuscular, intravenous use, made by 11 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Before reconstitution Do not store lyophilized powder above 25°C (77°F)…

Key facts

Active ingredient (INN)
Ertapenem
Brand
Sold under the generic name
Strength
1 g
Dosage form
Powder for injection
Route
Intramuscular, intravenous
Packs
10 vials, 5 vials and 12 more
Manufacturers
Dr. Reddy's LaboratoriesIndiaGland PharmaIndiaEndoFosun PharmaHikma PharmaceuticalsSagent PharmaceuticalsFresenius KabiHospiraNorthStar RxLLCQilu Antibiotics Pharmaceutical
Origin register
US FDA, United States
Storage
Before reconstitution Do not store lyophilized powder above 25°C (77°F). Reconstituted and infusion solutions The reconstituted solution, immediately diluted in 0.9% Sodium Chloride Injection, may be stored at room temperature (25°C) and used within 6 hours or stored for 24 hours under refrigeration (5°C) and used within 4 hours after removal from refrigeration.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
J01DH03 Ertapenem
HS code (indicative)
3004.20Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
26 July 2018
Identifiers
RxCUI 1734683DailyMed set ID b88c0709-33fe-47db-8ae8-8bad6692d5d5, 2398d418-6efc-b4d2-3265-936001df9b8b, 124775ed-1271-4581-be52-b7a08c91283d +11NDC 0143-9429, 16714-889, 25021-199 +9Application ANDA218067, ANDA212040, NDA021337 +1

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
10 vial, single-dose in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial, single-dose43598-901-58Dr. Reddy's LaboratoriesIndia29 April 2021
10 vial, single-dose in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial, single-dose68083-351-10Gland PharmaIndia26 March 2021
10 vial, single-dose in 1 package / 1 injection, powder, lyophilized, for solution in 1 vial, single-dose42023-221-10Endo26 July 2018
10 vial, single-dose in 1 package / 1 injection, powder, lyophilized, for solution in 1 vial, single-dose42023-221-85Endo1 November 2018
10 vial, single-dose in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial, single-dose0143-9398-10Hikma Pharmaceuticals2 August 2021
10 vial, single-dose in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial, single-dose0143-9429-10Hikma Pharmaceuticals28 February 2025
10 vial in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial25021-199-20Sagent Pharmaceuticals15 August 2025
10 vial in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial25021-199-66Sagent Pharmaceuticals15 January 2026
5 vial, single-dose in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial, single-dose72266-159-05Fosun Pharma9 December 2022
10 vial, single-dose in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial, single-dose72266-159-10Fosun Pharma1 November 2021
10 vial, single-dose in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial, single-dose63323-823-20Fresenius Kabi10 October 2019
10 vial, single-dose in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial, single-dose0409-3510-22Hospira19 October 2020
10 vial, single-dose in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial, single-dose51810-504-02Qilu Antibiotics Pharmaceutical31 October 2024
10 vial, single-dose in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial, single-dose44567-820-10WG Critical Care7 January 2020
10 vial, single-dose in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial, single-dose16714-889-10NorthStar RxLLC13 July 2021

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 21 November 2001Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Ertapenem 1 g powder for injection.

Compare 1

Other strengths and forms of Ertapenem

Clinical summary

Ertapenem is a penem antibacterial indicated in adult patients and pediatric patients (3 months of age and older) for the treatment of moderate to severe infections caused by susceptible bacteria, among other approved uses. MedsAcross supplies Ertapenem for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Ertapenem

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Ertapenem 1 g powder for injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.